TheProfitWatch

CRVO - CervoMed Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.21 0.05 (0.61%) --- --- --- --- -0.17 (-2.07%) 0.0 (0.0%) 0.0 (0.0%)

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.7
Diluted EPS:
Basic P/E:
-11.8
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
8.26
RVol:
0.6496

Events

Period Kind Movement Occurred At
1m Price increase 1m 8.15 +0.13 (+1.67%) Oct 15 09:42

Related News